BUSINESS INTELLIGENCE FOR PHARMA SL
Company details
- Active NIF/CIF: B65513855
-
Telephone: Not available
-
Date of last BORME entry: 13/02/2014
-
Sector: Construcción
-
Address: Carrer de Llull, 321, 08019 Barcelona, Barcelona, España See in map
-
Website: Not available
-
Featured products:
More information on BUSINESS INTELLIGENCE FOR PHARMA SL
-
13/02/2014 | BORME act no.: 67647 | Register: BARCELONAOtros conceptos -
15/01/2014 | BORME act no.: 13873 | Register: BARCELONARevocaciones
-
15/01/2014 | BORME act no.: 13873 | Register: BARCELONANombramientos
-
15/01/2014 | BORME act no.: 13873 | Register: BARCELONAModificaciones estatutarias
-
31/03/2011 | BORME act no.: 144059 | Register: BARCELONAConstitución
-
31/03/2011 | BORME act no.: 144059 | Register: BARCELONANombramientos
-
31/03/2011 | BORME act no.: 144059 | Register: BARCELONAOtros conceptos
Other information
The CIF of BUSINESS INTELLIGENCE FOR PHARMA SL is B65513855 and its business status is active. Its economic activity belongs to the CNAE 412 - Construcción de edificios. Its SIC is 1542 - Contratistas generales.
BUSINESS INTELLIGENCE FOR PHARMA SL has Between 1 and 9 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona. It has a total of 2 registration charges. Its last announcement in Borme was published on 13/02/2014 and the latest ordinary annual accounts are from the year -.
You can review the contact information of BUSINESS INTELLIGENCE FOR PHARMA SL such as the phone number, address, or website in the Company Data module.
For more information about BUSINESS INTELLIGENCE FOR PHARMA SL, you can consult any of our available financial reports, the Annual Accounts of the company, or even check its payment incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about the company name comes from official sources and is updated daily.
Do you want to know more about BUSINESS INTELLIGENCE FOR PHARMA SL??
Find out more about this company by consulting these reports:
